Morgan Stanley Maintains Overweight on Colgate-Palmolive, Raises Price Target to $93
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Dara Mohsenian has maintained an Overweight rating on Colgate-Palmolive (NYSE:CL) and increased the price target from $85 to $93.
January 29, 2024 | 4:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has reaffirmed its Overweight rating on Colgate-Palmolive and raised the price target to $93, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst like Morgan Stanley suggests a strong conviction in Colgate-Palmolive's future performance. This typically instills confidence in investors and can lead to a short-term increase in the stock price as the market reacts to the positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100